Ken Fisher Biomarin Pharmaceutical Inc Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q2 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 13,545 shares of BMRN stock, worth $770,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,545
Previous 13,573
0.21%
Holding current value
$770,168
Previous $959,000
22.42%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BMRN
# of Institutions
668Shares Held
182MCall Options Held
1.22MPut Options Held
962K-
Black Rock Inc. New York, NY22.7MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$897 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$859 Million0.5% of portfolio
-
Viking Global Investors LP10.8MShares$614 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...